AIML and the Clinical Data Manager | Clinion
The Covid-19 pandemic has pushed the global clinical trial industry and regulators to rapidly adopt technology and accelerate clinical development. Along with other technologies, the adoption of AI & ML has moved forward at a much more rapid pace than initially envisioned. Similar to remote technologies, AIML technologies have gone beyond users’ expectations and have quickly occupied a central position in an organization’s plans for the future. Pfizer’s 45,000 subject Covid-19 vaccine study which was completed in record time with the help of AIML is a case in point.
Read more https://www.clinion.com/insight/aiml-and-the-clinical-data-manager/
About the Author
Associative Manager for Clinical site in Clinion
Submitted on: 2021-10-25 05:05:37